Cargando…
Dasatinib-Induced Nephrotic Syndrome: A Case Report
Second-generation tyrosine kinase inhibitors (TKI), such as nilotinib and dasatinib, are used in the first-line treatment of chronic myeloid leukemia (CML), usually after the failure or resistance to imatinib. Despite a good safety profile, medications in this category have an increased incidence of...
Autores principales: | ElShaer, Ahmed, Almasry, Mazen, Alawar, Maher, Masoud, Hassan, El Kinge, Abdul Rahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665416/ https://www.ncbi.nlm.nih.gov/pubmed/34912656 http://dx.doi.org/10.7759/cureus.20330 |
Ejemplares similares
-
The Hidden Variable: A Case of Dasatinib-Induced Respiratory Failure
por: Drekolias, Dimitrios, et al.
Publicado: (2020) -
A Case Report of Nephrotic Syndrome While Undergoing Quinine Therapy
por: Albrecht, Brittany, et al.
Publicado: (2018) -
Dasatinib-induced nephrotic syndrome: a case of phenoconversion?
por: Mandac Rogulj, Inga, et al.
Publicado: (2019) -
Recurrent Chylous Pleural Effusions in a Patient Treated With Dasatinib
por: Nasir, Syed Alishan, et al.
Publicado: (2022) -
A Case of a Thrombotic Storm (Arterial and Venous) in Nephrotic Syndrome
por: Wireko, Felix, et al.
Publicado: (2022)